PAR-24-105: Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2024.
National Institutes of Health offered grants to small businesses. Applications closed on September 1, 2024.
From the official notice on Grants.gov, last changed January 3, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU42
- Clinical trialsNot allowed
- Funded byOD
- Median yearly award$839,625
- Typical project length30 years
Projects funded under PAR-24-105 were run by NIH Office of the Director (OD, 4 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-24-105 in the NIH Guide.
Key dates
| Posted | January 3, 2024 |
|---|---|
| Deadline | September 1, 2024 |
| Archived by Grants.gov | October 7, 2024 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. See full Notice of Funding Opportunity for additional details on eligibility.
Is this a realistic fit?
- Most of the program's money (80% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This Notice of Funding Opportunity (NOFO) invites applications for the continued support and advancement of the Mutant Mouse Resource and Research Centers (MMRRC). The MMRRC consortium is expected to facilitate research by identifying, acquiring, evaluating, characterizing, cryopreserving, and distributing mutant mouse strains to qualified biomedical investigators. A regional network of four MMRRCs and an Informatics, Coordination and Service Center (ICSC) collectively serve the needs of the biomedical research community for transgenic, knockout and other genetically-engineered mutant mice and related biomaterials. MMRRC strains are held to the highest standards to optimize reproducibility of studies and assure scientific rigor and transparency; all submitted strains are thoroughly reviewed and documented and include additional quality control measures. The Program Director/Principal Investigator (PD/PI) of each MMRRC in addition to the major resource activities is required to develop a small high risk, high return, research pilot project that complements the goals and needs of the MMRRC consortium.
Funded under PAR-24-105 so far
NIH funded 4 projects under PAR-24-105 in fiscal 2025 to 2026, at 4 institutions. The median yearly award was $839,625.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Mutant Mouse Resource and Research Center (MMRRC) at UC Davis | University of California at Davis | 2026 | $1.4 million |
| The Mutant Mouse Resource and Research Center at The Jackson Laboratory | Jackson Laboratory | 2026 | $1.3 million |
| Novel pH-Sensitive Particles for Noninvasive Upper GI Tract Microbiota Sampling | University of Missouri-Columbia | 2026 | $511,966 |
| Project 1 - Genetics of male infertility in the Collaborative Cross resource | Univ of North Carolina Chapel Hill | 2026 | $84,766 |
Who has won Research Infrastructure Programs grants before
From fiscal 2021 to 2025, Research Infrastructure Programs (93.351) awarded $1.4 billion across 1,102 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of California, Davis | California | 27 | $102 million |
| Oregon Health & Science University | Oregon | 18 | $92.1 million |
| University of Washington | Washington | 7 | $79.5 million |
| Emory University | Georgia | 14 | $78.3 million |
| The Administrators of Tulane Educational Fund | Louisiana | 10 | $68.0 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-24-105 still open?
No. It closed on September 1, 2024.
Who can apply for Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)?
Closed September 1, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-24-105?
NIH RePORTER lists 4 projects funded under PAR-24-105 in fiscal 2025 to 2026, at 4 institutions. The most were at University of California at Davis, Jackson Laboratory, University of Missouri-Columbia.
Who has won Research Infrastructure Programs grants before?
The largest recipients over five fiscal years were University of California, Davis, Oregon Health & Science University, University of Washington. The program made 1,102 awards worth $1.4 billion in that time.
Similar open grants
- Research Resource for a National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)
- Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)
- Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)